<DOC>
	<DOCNO>NCT01926288</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Entecavir maleate tablet Chinese patient hepatitis B</brief_summary>
	<brief_title>Efficacy Safety Entecavir Maleate Tablets Chinese Patients With Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>1 . Subjects diagnose HBeAg positive negative chronic hepatitis B 2 . Aged 18 70 year old，male female 3 . Patients previously HBsAgpositive , HBeAgpositive 24 week , HBVDNA &gt; 105copies/ml . HBeAgnegative 24 week , HBVDNA &gt; 105 copies/ml . 4 . 1.3 time upper normal limit ( 1.3 × ULN ) ≤ alanine aminotransferase ( ALT ) ≤ 10 × ULN . 5 . Total serum bilirubin ( TBIL ) ≤ 2.5 × ULN . 6 . Prothrombin activity ( PTA ) ≥ 60 % prothrombin time prolong normal ≤ 3 second ) . 7 . WBC ≥ 3.5 × 109 / L , PLT ≥ 70 × 109 / L , serum albumin ( ALB ) ≥ 35 g / L. 8 . Creatinine ( Cr ) ≤ 1.5 × ULN . 9 . If patient take intermittently interferon , nucleoside ( acid ) analogue , α1 thymosin enrollment 24 week , time 12 week . 10 . Patients sign informed consent form compliance good . 1 . Patients infected virus HAV , HCV , HDV , HEV , CMV , EBV , HIV etc . 2 . Patients cirrhosis liver cancer . 3 . Patients participate another therapeutic clinical trial 3 month . 4 . Granulocyte count &lt; 1.5 × 109 / L , hemoglobin ( HB ) &lt; 100g / L , serum alphafetoprotein ( AFP ) &gt; 100μg / L , patient ' B ultrasonography point spaceoccupying lesion . 5 . Patients severe heart , kidney , endocrine hematopoietic system neuropsychiatric disease . 6 . Patients metabolic autoimmune disease systemic lupus erythematosus . 7 . Pregnant woman , lactate woman wre allergic study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>